Details of the Optogenetic System
| General Information of This Optogenetic System (OS) | ||||||
|---|---|---|---|---|---|---|
| OS ID |
OS00278
|
|||||
| OS Name |
Tamoxifen-gated photoactivatable split-Cre recombinase optogenetic system
(TamPA-Cre)
|
[1] | ||||
|
Photoreceptor (PR) |
||||||
| Complementary Protein | Positive Magnet (pMag) | |||||
| Cofactor | Flavin adenine dinucleotide (FAD) | |||||
| Controlled Protein | Fusion protein | CreN means N terminal of Cre recombinase and CreC means C terminal of Cre recombinase | ||||
| Estrogen receptor ligand binding domain ERT2 | ||||||
| Recruited protein | CreN means N terminal of Cre recombinase and CreC means C terminal of Cre recombinase | |||||
| OS Application Information (1) | ||||||
|---|---|---|---|---|---|---|
| Mechanism of Action | nMag-pMag heterodimerization | [ 1] | ||||
| Controlled Signal Pathway | Tamoxifen dependent gene activation | |||||
| Effect | Activation | |||||
| Application | Specifically control localized CAR expression and subsequently T cell activation | |||||
| Note | Tamoxifen (500 nM) needed at the same time to activate the switch | |||||
| Light Information | Activation Wavelength | 473 ± 29 nm | ||||
| Process | Reversible | |||||
| Deactivation Wavelength | Dark | |||||
| Activation Time | Seconds | |||||
| Deactivation Time | Seconds to Minutes | |||||
| Light Intensity | 5 watts per square meter | |||||
| Expression Information | Expression Method | Transduction and Transfection | ||||
| Cell Lines | CAR reporter jurkat T cells lines and HEK293T cells | |||||